Pain control study for oral cancer surgery
Part of Cancer, Mouth & dental clinical trials.
This study tests two different pain medicines (dezocine or nalbuphine) combined with sufentanil to see which helps better control pain after oral cancer surgery with free flap reconstruction. It also looks at side effects and how well the transplanted tissue survives.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have been diagnosed with oral cancer (a malignant tumor in your mouth).
- You are scheduled for oral cancer surgery that uses a free flap (a piece of tissue from another part of your body) to rebuild the surgery area.
- You have not used pain medications in the last two weeks.
- You do not have diabetes, hardened arteries, or blood vessel disease.
- You are not currently using hormones, chemotherapy, or immune-suppressing drugs.
- You are not allergic to the study drugs (dezocine, nalbuphine, or sufentanil).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two medicines, sufentanil and methadone, for pain control after head and neck surgery that uses a flap to rebuild tissue. The goal is to find which option works better and has fewer side effects.
This trial tests two different pain medicines given after surgery to see which one helps patients recover better and feel better sooner. One is a tablet placed under the tongue, and the other is a standard opioid painkiller.
This study tests a new non-opioid pain medicine called suzetrigine compared to the usual pain relievers (like ibuprofen and acetaminophen) after skin cancer surgery on the head or neck. The goal is to see if it controls pain just as well with fewer side effects.
This trial tests if a newer painkiller (oliceridine) causes less nausea after a specific type of brain surgery than the standard painkiller (sufentanil). If you are having CPA region surgery and will receive a patient-controlled pain pump, this study may help find a better option for managing pain with fewer side effects.
This study tests whether adding a sedative medicine to the numbing medication used in a nerve block can improve pain relief after upper abdominal cancer surgery. It may help reduce pain and the need for strong painkillers after the operation.
This study tests whether a new pain medication called 3D1002, when combined with a long-acting opioid, can better manage moderate to severe cancer pain compared to the opioid alone. The goal is to find a more effective way to reduce pain without increasing side effects.
Hear when a new Oral Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.